Volume Alert - OPK 8.63 Opko Health Inc $OPK Hit a high today of 8.73 Closing the day 11/10/14 at 8.63 +0.31 +3.73% With a day low of 8.30 and a total volume of 6,270,480.
OPK Recent Posts: http://investorshangout.com/Opko-Health-Inc-OPK-52210/
OPK Opko Health Inc Recent Headline News
OPKO Health's (OPK) CEO Phillip Frost on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 12:09PM CST
OPK: 8.63 (+0.31)
Global Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Pipeline Report H2 2014 - Analysis of 27 Companies & 39 Drug Profiles
M2 - Mon Nov 10, 10:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/n5l8s3/chronic_kidney) has announced the addition of the "Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure) and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Hospira, Inc. - AstraZeneca PLC - Eli Lilly and Company - Quark Pharmaceuticals, Inc. - Astellas Pharma Inc. - OPKO Health, Inc. - Toray Industries, Inc. - Evotec AG - NPS Pharmaceuticals, Inc. - La Jolla Pharmaceutical Company - Alexion Pharmaceuticals, Inc. - AFFiRiS AG - Acceleron Pharma, Inc. - Nippon Zoki Pharmaceutical Co., Ltd. - Catabasis Pharmaceuticals, Inc. - Angion Biomedica Corp. - Concert Pharmaceuticals, Inc. - Intercept Pharmaceuticals, Inc. - Vitae Pharmaceuticals, Inc. - TRACON Pharmaceuticals, Inc. - Stelic Institute & Co. - Vicore Pharma AB - Otsuka Holdings Co., Ltd. - Sphaera Pharma Pvt. Ltd. - Multi Gene Vascular Systems Ltd - Bio-inRen - Red Glead Discovery AB For more information visit http://www.researchandmarkets.com/research/n5...nic_kidney
VTAE: 16.39 (+1.95), LLY: 68.35 (+1.75), CNCE: 13.37 (+0.27), OPK: 8.63 (+0.31), AZN: 73.21 (+0.33), ALXN: 195.80 (+1.99), ICPT: 176.35 (+3.76), NPSP: 26.91 (-0.58), XLRN: 32.26 (+2.07)
OPKO Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscore(TM) Test for High Grade Prostate Cancer in the United States
Business Wire - Mon Nov 10, 7:37AM CST
OPKO Health, Inc. (NYSE:OPK) today announced the online publication of a multi-institutional, prospective study of the 4Kscore Test in the journal European Urology. The results of the study demonstrated that the 4Kscore provides a patient with accurate and personalized information about their risk of having Gleason Score greater-than or equal to7 prostate cancer, making it a useful tool for selecting men who have significant disease and are most likely to benefit from a prostate biopsy.
OPK: 8.63 (+0.31)
Cramer's Lightning Round - Let's Buy Skyworks (11/7/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Sun Nov 09, 9:59AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday November 7. Bullish Calls: Skyworks Solutions (NASDAQ: SWKS ): "Why don't we buy Skyworks Solutions? I like the proprietary nature of it."...
MU: 33.09 (+0.08), LMT: 186.99 (+0.84), SWKS: 60.97 (+1.09), OPK: 8.63 (+0.31), AVAV: 29.30 (-0.51), QCOM: 69.36 (+0.10), TXN: 51.56 (+0.66), BPL: 78.62 (-0.68), SDRL: 21.76 (-0.01)
'Mad Money' Lightning Round: I'm Going Nowhere Near Sony
at The Street - Sat Nov 08, 5:00AM CST
Cramer likes Skyworks Solutions over Micron, Kinder Morgan over Buckeye Partners and thinks SeaDrill is a house of pain.
KMI: 38.50 (-0.25), MU: 33.09 (+0.08), LMT: 186.99 (+0.84), SWKS: 60.97 (+1.09), OPK: 8.63 (+0.31), TXN: 51.56 (+0.66), QCOM: 69.36 (+0.10), BPL: 78.62 (-0.68), AVAV: 29.30 (-0.51), IRM: 37.64 (-0.41), SNE: 20.50 (+0.88), SDRL: 21.76 (-0.01)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Nov 07, 7:19PM CST
Next week Cramer will be watching earnings from WhiteWave Foods, DR Horton and Wal-Mart, among many others.
DHI: 23.43 (+0.30), KMI: 38.50 (-0.25), HK: 3.25 (+0.01), KSS: 56.57 (-0.65), GE: 26.47 (+0.06), LMT: 186.99 (+0.84), AVAV: 29.30 (-0.51), WMT: 79.44 (+0.67), SNE: 20.50 (+0.88), M: 59.26 (-0.62), SDRL: 21.76 (-0.01), T: 35.12 (+0.21), W: 28.10 (+2.09), OPK: 8.63 (+0.31), QCOM: 69.36 (+0.10), TWTR: 39.59 (-0.72), EPR: 57.48 (+0.87), AAPL: 108.83 (-0.18), HSIC: 129.62 (+0.78), CSCO: 25.15 (-0.18), WFM: 48.05 (+1.24), CY: 10.16 (+0.08), MU: 33.09 (+0.08), SWKS: 60.97 (+1.09), IRM: 37.64 (-0.41), BAC: 17.37 (+0.01), MO: 49.87 (unch), CSX: 36.56 (+1.11), WWAV: 36.00 (-0.93), GILD: 107.02 (+0.57), TXN: 51.56 (+0.66), BPL: 78.62 (-0.68), JCP: 7.22 (-0.60), JWN: 72.39 (-1.04), BABA: 119.15 (+4.59)
InsiderInsights.com Daily Round Up 11/6/14: Chimerix, Biolase, Barrett Business Services, Ares Capital
InsiderInsights - at Seeking Alpha - Fri Nov 07, 1:06PM CST
74.36 (+0.47), CBG: 31.81 (-0.07), PBFX: 25.45 (+0.26), LLY: 68.35 (+1.75), RL: 171.92 (-2.08), GOOG: 547.49 (+6.48), AER: 44.17 (unch), DO: 37.47 (-1.27), TPVG: 14.69 (+0.10), ARCC: 16.33 (+0.04), CMRX: 31.82 (+1.07), OPK: 8.63 (+0.31), BIOL: 2.31 (-0.07), WRI: 36.96 (+0.36), BBSI: 24.28 (-0.95), CUDA: 33.15 (+1.13), ACGL: 57.26 (-0.22), KPTI: 42.68 (+0.54)
Opko earnings call Monday
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 11:02AM CST
OPK: 8.63 (+0.31)
OPKO To Hold Conference Call on November 10, 2014
Business Wire - Fri Nov 07, 10:31AM CST
OPKO Health, Inc. (NYSE:OPK) will hold a conference call to provide a business update and discuss its third quarter 2014 financial results on Monday, November 10, 2014, before the market opens. OPKO's senior management team will host a conference call and live audio webcast at 8:30 a.m. ET on Monday, November 10, 2014 to discuss the Company's results in greater detail.
OPK: 8.63 (+0.31)
OPKO Health misses 3Q revenue forecasts
Automated Insights - Fri Nov 07, 7:45AM CST
MIAMI (AP) _ Opko Health Inc. (OPK) on Friday reported a loss of $48.7 million, or 11 cents per share, in its third quarter.
OPK: 8.63 (+0.31)
Biotech Equities Scrutiny - Vanda Pharma, PDL BioPharma, Synergy Pharma, OPKO Health, and MiMedx
PR Newswire - Fri Nov 07, 7:35AM CST
Investor-Edge has initiated coverage on the following equities: Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), PDL BioPharma Inc. (NASDAQ: PDLI), Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), OPKO Health Inc. (NYSE: OPK), and MiMedx Group Inc. (NASDAQ: MDXG). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, November 6, 2014, the NASDAQ Composite ended at 4,638.47, up 0.38%, the Dow Jones Industrial Average advanced 0.40%, to finish the day at 17,554.47, and the S&P 500 closed at 2,031.21, up 0.38%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 782.64, up 0.57%, with the index also advancing 11.74% in the previous three months. Register for your complimentary reports on these five stocks at:
SGYP: 3.24 (+0.08), OPK: 8.63 (+0.31), VNDA: 12.16 (+0.37), MDXG: 10.11 (-0.13), PDLI: 7.93 (-0.05)
OPKO Health misses by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 7:32AM CST
OPK: 8.63 (+0.31)
OPKO Announces Third Quarter Operating and Financial Results
Business Wire - Fri Nov 07, 7:28AM CST
--Rayaldee Results to be Presented at American Society of Nephrologists Meeting
OPK: 8.63 (+0.31)
InsiderInsights.com Daily Round Up 11/5/14: ELGX, NS, BIOL, NHF
InsiderInsights - at Seeking Alpha - Thu Nov 06, 3:19AM CST
VR: 39.79 (-0.08), JBHT: 81.12 (+1.16), FCX: 28.02 (-0.32), BBY: 34.71 (-0.47), NS: 60.14 (-0.06), LL: 55.85 (-0.72), ELGX: 11.63 (+0.37), ENFC: 13.89 (+0.04), RCL: 67.98 (+0.78), LMCA: 35.82 (-0.55), SPW: 92.73 (-0.13), OPK: 8.63 (+0.31), BIOL: 2.31 (-0.07), IMI: 2.22 (+0.02), NHF: 10.96 (+0.04), SIX: 39.93 (-0.12), TWTR: 39.59 (-0.72), SCHW: 28.92 (+0.34)
DSG and OPKO Health Enter into Enterprise Licensing Agreement for Fully Integrated EDC, IWRS, Safety, and Trial Management Solution
Business Wire - Tue Nov 04, 9:14AM CST
OPKO Health, Inc., a multinational pharmaceutical & diagnostics company, has selected DSG's eCaseLink integrated suite for self-building of harmonized electronic data capture (EDC), IWRS, drug safety event capture and case reporting, and CTMS systems. DSG's team will support the OPKO team and their Site users 24 x 365.
OPK: 8.63 (+0.31)
Insider Buys And Sells: AGCO Corporation, Microsoft Corporation
Asif Suria - Seeking Alpha - Mon Nov 03, 10:09AM CST
Welcome to edition 228 of Insider Weekends. Insider buying increased last week with insiders buying $63.4 million of stock compared to $56.48 million in the week prior. Selling also increased significantly with insiders selling $1.51 billion of stock...
TTS: 8.84 (+0.11), OPK: 8.63 (+0.31), AGCO: 45.24 (-0.31), CATY: 26.56 (+0.27), EMC: 29.16 (+0.04), MSFT: 48.89 (+0.21), AAPL: 108.83 (-0.18), DOW: 49.48 (-0.02), SCHW: 28.92 (+0.34), UFI: 27.75 (-0.44)
InsiderInsights.com Daily Round Up 10/31/14: TTS, UFI, OPK, AAMC
InsiderInsights - at Seeking Alpha - Sun Nov 02, 11:12PM CST
SHLX: 35.62 (+1.44), VFC: 70.62 (+0.83), BBY: 34.71 (-0.47), AAMC: 536.99 (+13.00), BTN: 4.15 (-0.07), LLY: 68.35 (+1.75), FET: 27.73 (+0.03), SIEN: 18.00 (unch), TTS: 8.84 (+0.11), UA: 68.34 (+1.36), SPW: 92.73 (-0.13), AHGP: 68.31 (-0.29), OPK: 8.63 (+0.31), CATY: 26.56 (+0.27), MSFT: 48.89 (+0.21), AAPL: 108.83 (-0.18), UFI: 27.75 (-0.44), SCHW: 28.92 (+0.34)
Insider Trading Recap for Alpha Pro Tech, Opko Health, Yelp, Glu Mobile, Lakeland Industries, and Plug Power
PR Newswire - Fri Oct 31, 7:45AM CDT
Insiderslab.com, an US market research community has a special focus on updating investors with insider trading news, reveals the latest insider trading alerts for the US stock investors, who can access these reports through the links below, including stock performance, insider trading signals, and visual results. The reports cover the stocks of Alpha Pro Tech (NYSEMKT:APT), Opko Health (NYSE:OPK), Yelp (NYSE:YELP), Glu Mobile (NASDAQ:GLUU), Lakeland Industries (NASDAQ:LAKE), and Plug Power (NASDAQ
LUG).
OPK: 8.63 (+0.31), PLUG: 5.28 (-0.02), APT: 3.11 (-0.15), LAKE: 12.98 (-0.31), GLUU: 3.79 (+0.08), YELP: 59.07 (+0.66)
InsiderInsights.com Daily Round Up 10/30/14: CUDA, HSON, UFI, OPK
InsiderInsights - at Seeking Alpha - Fri Oct 31, 5:56AM CDT
ESL: 116.54 (+0.59), GD: 140.82 (+0.68), ATLS: 36.87 (-0.45), WAL: 26.78 (+0.26), BBW: 18.00 (+0.22), CHMG: 28.21 (-0.14), HSON: 3.40 (-0.10), CLF: 11.04 (-0.13), PRTO: 10.09 (-0.06), PM: 88.42 (+0.30), GIMO: 14.64 (+0.34), OPK: 8.63 (+0.31), CUDA: 33.15 (+1.13), CBNJ: 9.15 (+0.05), QLYS: 36.00 (+1.52), MSFT: 48.89 (+0.21), VCV: 12.47 (+0.01), MMS: 49.46 (+0.27), UFI: 27.75 (-0.44), CRM: 64.45 (+0.48)
5 Stocks Insiders Love Right Now
at The Street - Wed Oct 29, 12:00PM CDT
Insiders at these companies have been scooping up shares of their own stock lately.
AGO: 24.58 (+0.05), OPK: 8.63 (+0.31), JONE: 12.76 (-0.78), SHLD: 38.72 (-4.09), SLB: 98.29 (-0.44)
OPK Recent Posts: http://investorshangout.com/Opko-Health-Inc-OPK-52210/
OPK Opko Health Inc Recent Headline News
OPKO Health's (OPK) CEO Phillip Frost on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 12:09PM CST
OPK: 8.63 (+0.31)
Global Chronic Kidney Disease (Chronic Renal Failure) Therapeutics Pipeline Report H2 2014 - Analysis of 27 Companies & 39 Drug Profiles
M2 - Mon Nov 10, 10:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/n5l8s3/chronic_kidney) has announced the addition of the "Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Kidney Disease (Chronic Renal Failure) and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Hospira, Inc. - AstraZeneca PLC - Eli Lilly and Company - Quark Pharmaceuticals, Inc. - Astellas Pharma Inc. - OPKO Health, Inc. - Toray Industries, Inc. - Evotec AG - NPS Pharmaceuticals, Inc. - La Jolla Pharmaceutical Company - Alexion Pharmaceuticals, Inc. - AFFiRiS AG - Acceleron Pharma, Inc. - Nippon Zoki Pharmaceutical Co., Ltd. - Catabasis Pharmaceuticals, Inc. - Angion Biomedica Corp. - Concert Pharmaceuticals, Inc. - Intercept Pharmaceuticals, Inc. - Vitae Pharmaceuticals, Inc. - TRACON Pharmaceuticals, Inc. - Stelic Institute & Co. - Vicore Pharma AB - Otsuka Holdings Co., Ltd. - Sphaera Pharma Pvt. Ltd. - Multi Gene Vascular Systems Ltd - Bio-inRen - Red Glead Discovery AB For more information visit http://www.researchandmarkets.com/research/n5...nic_kidney
VTAE: 16.39 (+1.95), LLY: 68.35 (+1.75), CNCE: 13.37 (+0.27), OPK: 8.63 (+0.31), AZN: 73.21 (+0.33), ALXN: 195.80 (+1.99), ICPT: 176.35 (+3.76), NPSP: 26.91 (-0.58), XLRN: 32.26 (+2.07)
OPKO Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscore(TM) Test for High Grade Prostate Cancer in the United States
Business Wire - Mon Nov 10, 7:37AM CST
OPKO Health, Inc. (NYSE:OPK) today announced the online publication of a multi-institutional, prospective study of the 4Kscore Test in the journal European Urology. The results of the study demonstrated that the 4Kscore provides a patient with accurate and personalized information about their risk of having Gleason Score greater-than or equal to7 prostate cancer, making it a useful tool for selecting men who have significant disease and are most likely to benefit from a prostate biopsy.
OPK: 8.63 (+0.31)
Cramer's Lightning Round - Let's Buy Skyworks (11/7/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Sun Nov 09, 9:59AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday November 7. Bullish Calls: Skyworks Solutions (NASDAQ: SWKS ): "Why don't we buy Skyworks Solutions? I like the proprietary nature of it."...
MU: 33.09 (+0.08), LMT: 186.99 (+0.84), SWKS: 60.97 (+1.09), OPK: 8.63 (+0.31), AVAV: 29.30 (-0.51), QCOM: 69.36 (+0.10), TXN: 51.56 (+0.66), BPL: 78.62 (-0.68), SDRL: 21.76 (-0.01)
'Mad Money' Lightning Round: I'm Going Nowhere Near Sony
at The Street - Sat Nov 08, 5:00AM CST
Cramer likes Skyworks Solutions over Micron, Kinder Morgan over Buckeye Partners and thinks SeaDrill is a house of pain.
KMI: 38.50 (-0.25), MU: 33.09 (+0.08), LMT: 186.99 (+0.84), SWKS: 60.97 (+1.09), OPK: 8.63 (+0.31), TXN: 51.56 (+0.66), QCOM: 69.36 (+0.10), BPL: 78.62 (-0.68), AVAV: 29.30 (-0.51), IRM: 37.64 (-0.41), SNE: 20.50 (+0.88), SDRL: 21.76 (-0.01)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Nov 07, 7:19PM CST
Next week Cramer will be watching earnings from WhiteWave Foods, DR Horton and Wal-Mart, among many others.
DHI: 23.43 (+0.30), KMI: 38.50 (-0.25), HK: 3.25 (+0.01), KSS: 56.57 (-0.65), GE: 26.47 (+0.06), LMT: 186.99 (+0.84), AVAV: 29.30 (-0.51), WMT: 79.44 (+0.67), SNE: 20.50 (+0.88), M: 59.26 (-0.62), SDRL: 21.76 (-0.01), T: 35.12 (+0.21), W: 28.10 (+2.09), OPK: 8.63 (+0.31), QCOM: 69.36 (+0.10), TWTR: 39.59 (-0.72), EPR: 57.48 (+0.87), AAPL: 108.83 (-0.18), HSIC: 129.62 (+0.78), CSCO: 25.15 (-0.18), WFM: 48.05 (+1.24), CY: 10.16 (+0.08), MU: 33.09 (+0.08), SWKS: 60.97 (+1.09), IRM: 37.64 (-0.41), BAC: 17.37 (+0.01), MO: 49.87 (unch), CSX: 36.56 (+1.11), WWAV: 36.00 (-0.93), GILD: 107.02 (+0.57), TXN: 51.56 (+0.66), BPL: 78.62 (-0.68), JCP: 7.22 (-0.60), JWN: 72.39 (-1.04), BABA: 119.15 (+4.59)
InsiderInsights.com Daily Round Up 11/6/14: Chimerix, Biolase, Barrett Business Services, Ares Capital
InsiderInsights - at Seeking Alpha - Fri Nov 07, 1:06PM CST
74.36 (+0.47), CBG: 31.81 (-0.07), PBFX: 25.45 (+0.26), LLY: 68.35 (+1.75), RL: 171.92 (-2.08), GOOG: 547.49 (+6.48), AER: 44.17 (unch), DO: 37.47 (-1.27), TPVG: 14.69 (+0.10), ARCC: 16.33 (+0.04), CMRX: 31.82 (+1.07), OPK: 8.63 (+0.31), BIOL: 2.31 (-0.07), WRI: 36.96 (+0.36), BBSI: 24.28 (-0.95), CUDA: 33.15 (+1.13), ACGL: 57.26 (-0.22), KPTI: 42.68 (+0.54) Opko earnings call Monday
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 11:02AM CST
OPK: 8.63 (+0.31)
OPKO To Hold Conference Call on November 10, 2014
Business Wire - Fri Nov 07, 10:31AM CST
OPKO Health, Inc. (NYSE:OPK) will hold a conference call to provide a business update and discuss its third quarter 2014 financial results on Monday, November 10, 2014, before the market opens. OPKO's senior management team will host a conference call and live audio webcast at 8:30 a.m. ET on Monday, November 10, 2014 to discuss the Company's results in greater detail.
OPK: 8.63 (+0.31)
OPKO Health misses 3Q revenue forecasts
Automated Insights - Fri Nov 07, 7:45AM CST
MIAMI (AP) _ Opko Health Inc. (OPK) on Friday reported a loss of $48.7 million, or 11 cents per share, in its third quarter.
OPK: 8.63 (+0.31)
Biotech Equities Scrutiny - Vanda Pharma, PDL BioPharma, Synergy Pharma, OPKO Health, and MiMedx
PR Newswire - Fri Nov 07, 7:35AM CST
Investor-Edge has initiated coverage on the following equities: Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), PDL BioPharma Inc. (NASDAQ: PDLI), Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), OPKO Health Inc. (NYSE: OPK), and MiMedx Group Inc. (NASDAQ: MDXG). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, November 6, 2014, the NASDAQ Composite ended at 4,638.47, up 0.38%, the Dow Jones Industrial Average advanced 0.40%, to finish the day at 17,554.47, and the S&P 500 closed at 2,031.21, up 0.38%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 782.64, up 0.57%, with the index also advancing 11.74% in the previous three months. Register for your complimentary reports on these five stocks at:
SGYP: 3.24 (+0.08), OPK: 8.63 (+0.31), VNDA: 12.16 (+0.37), MDXG: 10.11 (-0.13), PDLI: 7.93 (-0.05)
OPKO Health misses by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 7:32AM CST
OPK: 8.63 (+0.31)
OPKO Announces Third Quarter Operating and Financial Results
Business Wire - Fri Nov 07, 7:28AM CST
--Rayaldee Results to be Presented at American Society of Nephrologists Meeting
OPK: 8.63 (+0.31)
InsiderInsights.com Daily Round Up 11/5/14: ELGX, NS, BIOL, NHF
InsiderInsights - at Seeking Alpha - Thu Nov 06, 3:19AM CST
VR: 39.79 (-0.08), JBHT: 81.12 (+1.16), FCX: 28.02 (-0.32), BBY: 34.71 (-0.47), NS: 60.14 (-0.06), LL: 55.85 (-0.72), ELGX: 11.63 (+0.37), ENFC: 13.89 (+0.04), RCL: 67.98 (+0.78), LMCA: 35.82 (-0.55), SPW: 92.73 (-0.13), OPK: 8.63 (+0.31), BIOL: 2.31 (-0.07), IMI: 2.22 (+0.02), NHF: 10.96 (+0.04), SIX: 39.93 (-0.12), TWTR: 39.59 (-0.72), SCHW: 28.92 (+0.34)
DSG and OPKO Health Enter into Enterprise Licensing Agreement for Fully Integrated EDC, IWRS, Safety, and Trial Management Solution
Business Wire - Tue Nov 04, 9:14AM CST
OPKO Health, Inc., a multinational pharmaceutical & diagnostics company, has selected DSG's eCaseLink integrated suite for self-building of harmonized electronic data capture (EDC), IWRS, drug safety event capture and case reporting, and CTMS systems. DSG's team will support the OPKO team and their Site users 24 x 365.
OPK: 8.63 (+0.31)
Insider Buys And Sells: AGCO Corporation, Microsoft Corporation
Asif Suria - Seeking Alpha - Mon Nov 03, 10:09AM CST
Welcome to edition 228 of Insider Weekends. Insider buying increased last week with insiders buying $63.4 million of stock compared to $56.48 million in the week prior. Selling also increased significantly with insiders selling $1.51 billion of stock...
TTS: 8.84 (+0.11), OPK: 8.63 (+0.31), AGCO: 45.24 (-0.31), CATY: 26.56 (+0.27), EMC: 29.16 (+0.04), MSFT: 48.89 (+0.21), AAPL: 108.83 (-0.18), DOW: 49.48 (-0.02), SCHW: 28.92 (+0.34), UFI: 27.75 (-0.44)
InsiderInsights.com Daily Round Up 10/31/14: TTS, UFI, OPK, AAMC
InsiderInsights - at Seeking Alpha - Sun Nov 02, 11:12PM CST
SHLX: 35.62 (+1.44), VFC: 70.62 (+0.83), BBY: 34.71 (-0.47), AAMC: 536.99 (+13.00), BTN: 4.15 (-0.07), LLY: 68.35 (+1.75), FET: 27.73 (+0.03), SIEN: 18.00 (unch), TTS: 8.84 (+0.11), UA: 68.34 (+1.36), SPW: 92.73 (-0.13), AHGP: 68.31 (-0.29), OPK: 8.63 (+0.31), CATY: 26.56 (+0.27), MSFT: 48.89 (+0.21), AAPL: 108.83 (-0.18), UFI: 27.75 (-0.44), SCHW: 28.92 (+0.34)
Insider Trading Recap for Alpha Pro Tech, Opko Health, Yelp, Glu Mobile, Lakeland Industries, and Plug Power
PR Newswire - Fri Oct 31, 7:45AM CDT
Insiderslab.com, an US market research community has a special focus on updating investors with insider trading news, reveals the latest insider trading alerts for the US stock investors, who can access these reports through the links below, including stock performance, insider trading signals, and visual results. The reports cover the stocks of Alpha Pro Tech (NYSEMKT:APT), Opko Health (NYSE:OPK), Yelp (NYSE:YELP), Glu Mobile (NASDAQ:GLUU), Lakeland Industries (NASDAQ:LAKE), and Plug Power (NASDAQ
LUG). OPK: 8.63 (+0.31), PLUG: 5.28 (-0.02), APT: 3.11 (-0.15), LAKE: 12.98 (-0.31), GLUU: 3.79 (+0.08), YELP: 59.07 (+0.66)
InsiderInsights.com Daily Round Up 10/30/14: CUDA, HSON, UFI, OPK
InsiderInsights - at Seeking Alpha - Fri Oct 31, 5:56AM CDT
ESL: 116.54 (+0.59), GD: 140.82 (+0.68), ATLS: 36.87 (-0.45), WAL: 26.78 (+0.26), BBW: 18.00 (+0.22), CHMG: 28.21 (-0.14), HSON: 3.40 (-0.10), CLF: 11.04 (-0.13), PRTO: 10.09 (-0.06), PM: 88.42 (+0.30), GIMO: 14.64 (+0.34), OPK: 8.63 (+0.31), CUDA: 33.15 (+1.13), CBNJ: 9.15 (+0.05), QLYS: 36.00 (+1.52), MSFT: 48.89 (+0.21), VCV: 12.47 (+0.01), MMS: 49.46 (+0.27), UFI: 27.75 (-0.44), CRM: 64.45 (+0.48)
5 Stocks Insiders Love Right Now
at The Street - Wed Oct 29, 12:00PM CDT
Insiders at these companies have been scooping up shares of their own stock lately.
AGO: 24.58 (+0.05), OPK: 8.63 (+0.31), JONE: 12.76 (-0.78), SHLD: 38.72 (-4.09), SLB: 98.29 (-0.44)
